BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 27151938)

  • 21. Cell expression patterns of CD147 in N-diethylnitrosamine/phenobarbital-induced mouse hepatocellular carcinoma.
    Lu M; Wu J; He F; Wang XL; Li C; Chen ZN; Bian H
    J Mol Histol; 2015 Feb; 46(1):79-91. PubMed ID: 25447507
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IKKbeta couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis.
    Maeda S; Kamata H; Luo JL; Leffert H; Karin M
    Cell; 2005 Jul; 121(7):977-90. PubMed ID: 15989949
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Romidepsin hepatocellular carcinoma suppression in mice is associated with deregulated gene expression of bone morphogenetic protein and Notch signaling pathway components.
    Afaloniati H; Poutahidis T; Giakoustidis A; Gargavanis A; Giakoustidis D; Angelopoulou K
    Mol Biol Rep; 2021 Jan; 48(1):551-562. PubMed ID: 33393006
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction of p53 renders ATM-deficient mice refractory to hepatocarcinogenesis.
    Teoh N; Pyakurel P; Dan YY; Swisshelm K; Hou J; Mitchell C; Fausto N; Gu Y; Farrell G
    Gastroenterology; 2010 Mar; 138(3):1155-65.e1-2. PubMed ID: 19919837
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-saturate-fat diet delays initiation of diethylnitrosamine-induced hepatocellular carcinoma.
    Duan XY; Pan Q; Yan SY; Ding WJ; Fan JG; Qiao L
    BMC Gastroenterol; 2014 Nov; 14():195. PubMed ID: 25410681
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potential Molecular Targets of Statins in the Prevention of Hepatocarcinogenesis.
    Ridruejo E; Romero-Caími G; Obregón MJ; Kleiman de Pisarev D; Alvarez L
    Ann Hepatol; 2018; 17(3):490-500. PubMed ID: 29735800
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatic transforming growth factor beta gives rise to tumor-initiating cells and promotes liver cancer development.
    Wu K; Ding J; Chen C; Sun W; Ning BF; Wen W; Huang L; Han T; Yang W; Wang C; Li Z; Wu MC; Feng GS; Xie WF; Wang HY
    Hepatology; 2012 Dec; 56(6):2255-67. PubMed ID: 22898879
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TLR4 Deficiency Protects against Hepatic Fibrosis and Diethylnitrosamine-Induced Pre-Carcinogenic Liver Injury in Fibrotic Liver.
    Weber SN; Bohner A; Dapito DH; Schwabe RF; Lammert F
    PLoS One; 2016; 11(7):e0158819. PubMed ID: 27391331
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhancement of DEN-induced liver tumourigenesis in hepatocyte-specific Lass2-knockout mice coincident with upregulation of the TGF-β1-Smad4-PAI-1 axis.
    Chen L; Lu X; Zeng T; Chen Y; Chen Q; Wu W; Yan X; Cai H; Zhang Z; Shao Q; Qin W
    Oncol Rep; 2014 Feb; 31(2):885-93. PubMed ID: 24337404
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of androgen/AR signaling inhibits diethylnitrosamine (DEN) induced tumour initiation and remodels liver immune cell networks.
    Helms TH; Mullins RD; Thomas-Ahner JM; Kulp SK; Campbell MJ; Lucas F; Schmidt N; LeMoine DM; Getaneh S; Xie Z; Phelps MA; Clinton SK; Coss CC
    Sci Rep; 2021 Feb; 11(1):3646. PubMed ID: 33574348
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adaptive immunity suppresses formation and progression of diethylnitrosamine-induced liver cancer.
    Schneider C; Teufel A; Yevsa T; Staib F; Hohmeyer A; Walenda G; Zimmermann HW; Vucur M; Huss S; Gassler N; Wasmuth HE; Lira SA; Zender L; Luedde T; Trautwein C; Tacke F
    Gut; 2012 Dec; 61(12):1733-43. PubMed ID: 22267597
    [TBL] [Abstract][Full Text] [Related]  

  • 32. GATA5 inhibits hepatocellular carcinoma cells malignant behaviours by blocking expression of reprogramming genes.
    Feng H; Zhu M; Zhang R; Wang Q; Li W; Dong X; Chen Y; Lu Y; Liu K; Lin B; Guo J; Li M
    J Cell Mol Med; 2019 Apr; 23(4):2536-2548. PubMed ID: 30672133
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extracellular ATP and Purinergic P2Y
    Schulien I; Hockenjos B; van Marck V; Ayata CK; Follo M; Thimme R; Hasselblatt P
    Cancer Res; 2020 Feb; 80(4):699-708. PubMed ID: 31822494
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum protein N-glycan alterations of diethylnitrosamine-induced hepatocellular carcinoma mice and their evolution after inhibition of the placental growth factor.
    Blomme B; Heindryckx F; Stassen JM; Geerts A; Colle I; Van Vlierberghe H
    Mol Cell Biochem; 2013 Jan; 372(1-2):199-210. PubMed ID: 23001868
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oral administration of cholic acid promotes growth of liver tumors initiated by diethylnitrosamine in rats.
    Shiota G; Oyama K; Noguchi N; Takano T; Ito H; Kawasaki H
    Int J Oncol; 1999 Aug; 15(2):259-65. PubMed ID: 10402235
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lipid droplet binding thalidomide analogs activate endoplasmic reticulum stress and suppress hepatocellular carcinoma in a chemically induced transgenic mouse model.
    Nagy LI; Molnár E; Kanizsai I; Madácsi R; Ózsvári B; Fehér LZ; Fábián G; Marton A; Vizler C; Ayaydin F; Kitajka K; Hackler L; Mátés L; Deák F; Kiss I; Puskás LG
    Lipids Health Dis; 2013 Nov; 12():175. PubMed ID: 24268070
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolic pathway analyses identify proline biosynthesis pathway as a promoter of liver tumorigenesis.
    Ding Z; Ericksen RE; Escande-Beillard N; Lee QY; Loh A; Denil S; Steckel M; Haegebarth A; Wai Ho TS; Chow P; Toh HC; Reversade B; Gruenewald S; Han W
    J Hepatol; 2020 Apr; 72(4):725-735. PubMed ID: 31726117
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CYP2E1 deficit mediates cholic acid-induced malignant growth in hepatocellular carcinoma cells.
    Hao Z; Liu X; He H; Wei Z; Shu X; Wang J; Sun B; Zhou H; Wang J; Niu Y; Hu Z; Hu S; Liu Y; Fu Z
    Mol Med; 2024 Jun; 30(1):79. PubMed ID: 38844847
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of insulin receptor substrates in the progression of hepatocellular carcinoma.
    Sakurai Y; Kubota N; Takamoto I; Obata A; Iwamoto M; Hayashi T; Aihara M; Kubota T; Nishihara H; Kadowaki T
    Sci Rep; 2017 Jul; 7(1):5387. PubMed ID: 28710407
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytokeratin 7/19 expression in N-diethylnitrosamine-induced mouse hepatocellular lesions: implications for histogenesis.
    Santos NP; Oliveira PA; Arantes-Rodrigues R; Faustino-Rocha AI; Colaço A; Lopes C; Gil da Costa RM
    Int J Exp Pathol; 2014 Jun; 95(3):191-8. PubMed ID: 24730441
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.